These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 26304108

  • 1. Design, synthesis and molecular docking of salicylic acid derivatives containing metronidazole as a new class of antimicrobial agents.
    Guo ZH, Yin Y, Wang C, Wang PF, Zhang XT, Wang ZC, Zhu HL.
    Bioorg Med Chem; 2015 Sep 15; 23(18):6148-56. PubMed ID: 26304108
    [Abstract] [Full Text] [Related]

  • 2. Synthesis, molecular docking and biological evaluation of metronidazole derivatives containing piperazine skeleton as potential antibacterial agents.
    Wang SF, Yin Y, Qiao F, Wu X, Sha S, Zhang L, Zhu HL.
    Bioorg Med Chem; 2014 Apr 15; 22(8):2409-15. PubMed ID: 24680059
    [Abstract] [Full Text] [Related]

  • 3. 3-Aryl-4-acyloxyethoxyfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: synthesis, molecular docking and antibacterial evaluation.
    Wang XD, Deng RC, Dong JJ, Peng ZY, Gao XM, Li ST, Lin WQ, Lu CL, Xiao ZP, Zhu HL.
    Bioorg Med Chem; 2013 Sep 01; 21(17):4914-22. PubMed ID: 23891164
    [Abstract] [Full Text] [Related]

  • 4. Metronidazole containing pyrazole derivatives potently inhibit tyrosyl-tRNA synthetase: design, synthesis, and biological evaluation.
    Chen LW, Wang PF, Tang DJ, Tao XX, Man RJ, Qiu HY, Wang ZC, Xu C, Zhu HL.
    Chem Biol Drug Des; 2016 Oct 01; 88(4):592-8. PubMed ID: 27206529
    [Abstract] [Full Text] [Related]

  • 5. Synthesis and evaluation of new tyrosyl-tRNA synthetase inhibitors as antibacterial agents based on a N2-(arylacetyl)glycinanilide scaffold.
    Xiao ZP, Wei W, Wang PF, Shi WK, Zhu N, Xie MQ, Sun YW, Li LX, Xie YX, Zhu LS, Tang N, Ouyang H, Li XH, Wang GC, Zhu HL.
    Eur J Med Chem; 2015 Sep 18; 102():631-8. PubMed ID: 26318069
    [Abstract] [Full Text] [Related]

  • 6. Tyrosyl-tRNA synthetase inhibitors as antibacterial agents: synthesis, molecular docking and structure-activity relationship analysis of 3-aryl-4-arylaminofuran-2(5H)-ones.
    Xiao ZP, Ma TW, Liao ML, Feng YT, Peng XC, Li JL, Li ZP, Wu Y, Luo Q, Deng Y, Liang X, Zhu HL.
    Eur J Med Chem; 2011 Oct 18; 46(10):4904-14. PubMed ID: 21856050
    [Abstract] [Full Text] [Related]

  • 7. 4-alkoxy-3-arylfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: synthesis, molecular docking and antibacterial evaluation.
    Xiao ZP, Ouyang H, Wang XD, Lv PC, Huang ZJ, Yu SR, Yi TF, Yang YL, Zhu HL.
    Bioorg Med Chem; 2011 Jul 01; 19(13):3884-91. PubMed ID: 21669535
    [Abstract] [Full Text] [Related]

  • 8. Synthesis, molecular docking and biological evaluation of coumarin derivatives containing piperazine skeleton as potential antibacterial agents.
    Wang SF, Yin Y, Wu X, Qiao F, Sha S, Lv PC, Zhao J, Zhu HL.
    Bioorg Med Chem; 2014 Nov 01; 22(21):5727-37. PubMed ID: 25306465
    [Abstract] [Full Text] [Related]

  • 9. Design, synthesis and antimicrobial activities of nitroimidazole derivatives containing 1,3,4-oxadiazole scaffold as FabH inhibitors.
    Li Y, Luo Y, Hu Y, Zhu DD, Zhang S, Liu ZJ, Gong HB, Zhu HL.
    Bioorg Med Chem; 2012 Jul 15; 20(14):4316-22. PubMed ID: 22710102
    [Abstract] [Full Text] [Related]

  • 10. Adenosine analogs as inhibitors of tyrosyl-tRNA synthetase: Design, synthesis and antibacterial evaluation.
    Wei W, Shi WK, Wang PF, Zeng XT, Li P, Zhang JR, Li Q, Tang ZP, Peng J, Wu LZ, Xie MQ, Liu C, Li XH, Wang YC, Xiao ZP, Zhu HL.
    Bioorg Med Chem; 2015 Oct 15; 23(20):6602-11. PubMed ID: 26404408
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis and antibacterial activities of vanillic acylhydrazone derivatives as potential β-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors.
    Wang XL, Zhang YB, Tang JF, Yang YS, Chen RQ, Zhang F, Zhu HL.
    Eur J Med Chem; 2012 Nov 15; 57():373-82. PubMed ID: 23124163
    [Abstract] [Full Text] [Related]

  • 12. Design, synthesis and biological evaluation of metronidazole-thiazole derivatives as antibacterial inhibitors.
    Qin YJ, Wang PF, Makawana JA, Wang ZC, Wang ZN, Yan-Gu, Jiang AQ, Zhu HL.
    Bioorg Med Chem Lett; 2014 Nov 15; 24(22):5279-83. PubMed ID: 25587588
    [Abstract] [Full Text] [Related]

  • 13. Design, synthesis ADMET and molecular docking of new imidazo[4,5-b]pyridine-5-thione derivatives as potential tyrosyl-tRNA synthetase inhibitors.
    Othman IMM, Gad-Elkareem MAM, Hassane Anouar E, Aouadi K, Kadri A, Snoussi M.
    Bioorg Chem; 2020 Sep 15; 102():104105. PubMed ID: 32717689
    [Abstract] [Full Text] [Related]

  • 14. Synthesis, structure and biological activity of pseudopeptidic macrolides based on an amino alcohol.
    Lv J, Liu T, Wang Y.
    Eur J Med Chem; 2008 Jan 15; 43(1):19-24. PubMed ID: 17507115
    [Abstract] [Full Text] [Related]

  • 15. Synthesis of 1-(4-methoxybenzyl)-3-cyclopropyl-1H-pyrazol-5-amine derivatives as antimicrobial agents.
    Raju H, Nagamani TS, Chandrappa S, Ananda H, Vinaya K, Thimmegowda NR, Byregowda SM, Rangappa KS.
    J Enzyme Inhib Med Chem; 2010 Aug 15; 25(4):537-43. PubMed ID: 20235748
    [Abstract] [Full Text] [Related]

  • 16. Novel cajaninstilbene acid derivatives as antibacterial agents.
    Geng ZZ, Zhang JJ, Lin J, Huang MY, An LK, Zhang HB, Sun PH, Ye WC, Chen WM.
    Eur J Med Chem; 2015 Jul 15; 100():235-45. PubMed ID: 26093280
    [Abstract] [Full Text] [Related]

  • 17. 5-Adamantan thiadiazole-based thiazolidinones as antimicrobial agents. Design, synthesis, molecular docking and evaluation.
    Fesatidou M, Zagaliotis P, Camoutsis C, Petrou A, Eleftheriou P, Tratrat C, Haroun M, Geronikaki A, Ciric A, Sokovic M.
    Bioorg Med Chem; 2018 Sep 01; 26(16):4664-4676. PubMed ID: 30107969
    [Abstract] [Full Text] [Related]

  • 18. Synthesis of a novel class of some 1,3,4-oxadiazole derivatives as antimicrobial agents.
    Chikhalia KH, Vashi DB, Patel MJ.
    J Enzyme Inhib Med Chem; 2009 Jun 01; 24(3):617-22. PubMed ID: 18642158
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and evaluation of adenosine containing 3-arylfuran-2(5H)-ones as tyrosyl-tRNA synthetase inhibitors.
    Wei W, Liu Q, Li ZZ, Shi WK, Fu X, Liu J, Zhu X, Wang XC, Xu N, Li TF, Jiang FR, Xiao ZP, Zhu HL.
    Eur J Med Chem; 2017 Jun 16; 133():62-68. PubMed ID: 28380394
    [Abstract] [Full Text] [Related]

  • 20. Synthesis, structure, molecular docking, and structure-activity relationship analysis of enamines: 3-aryl-4-alkylaminofuran-2(5H)-ones as potential antibacterials.
    Xiao ZP, He XB, Peng ZY, Xiong TJ, Peng J, Chen LH, Zhu HL.
    Bioorg Med Chem; 2011 Mar 01; 19(5):1571-9. PubMed ID: 21330140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.